The Mind strong Al-platformmonitors patterns of interaction on smartphone devices for the objective measurement of the brain function. It transforms one’s typing patterns on smartphones to measure the cognitive function. It provides information on the cognition biomarkers and mood that includes memory, speed, and function. According to Wired.com, this serves as a foundation for developing new interventions for improving mental health care.
The Mindstrong Health team gives an understanding of the challenges faced by medical community care facilities in providing care for patients of cognitive health disorders. Those who are working towards improving the patient outcomes will gain an innovative platform that improves the provision of care for the patients. The company also states that it intends to release the results of its clinical trial within the coming month.
Modern medicine is of objective measurement but tackling mental health is limited to subjective reports from clinical environments. There is a need to develop objective measures for tackling mental orders if at all we want to improve the condition of the patients. Mindstrong technology offers objective and continues measures of cognition and behaviour at a high level of insight and resolution that has not been achieved yet according to Dr.Paul Dagum who is the chief executive officer of Mindstrong Health.
Jim Tananbaum is the founder and chief executive officer of Foresite Capital Management. Jim Tananbaum has twenty five years of entrepreneurial and investment experience. He has an M.B.A from Harvard Business School and an M.D. from Harvard Medical School and a B.S from Yale University. Tananbaum has also served on the advisory boards and visiting committees to the Yale School of Engineering and Harvard-MIT HST program respectively. Jim Tananbaum is passionate about the link between hard sciences and health care and has productive relationships with many academicians. He is passionate about working across different fields with leading academicians and entrepreneurs with an aim of achieving growth and change in the field of learning science.
Jim Tananbaum has led twenty one successful healthcare firms that include Jazz Pharmaceuticals, Amira Pharmaceuticals and Amerigroup. Before Foresite Capital Management, he co-founded two biopharmaceutical companies; GelTex Pharmaceuticals and Theravance Biopharma where he was a co founder and chief executive officer. Visit the website, officialjimtananbaum.com.
Read More: https://ideamensch.com/jim-tananbaum/